![Petra Kaufmann](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Petra Kaufmann
Director Técnico/Científico/I+D en
OVID THERAPEUTICS INC.
.
Perfil
Petra Kaufmann is currently Chief Medical Officer at Ovid Therapeutics, Inc. since 2025.
Former positions include Chief Medical Officer at Affinia Therapeutics, Inc. from 2021 to 2024, SVP, Head-Clinical Development & Analytics at Novartis Gene Therapies, Inc. from 2020 to 2021, Director-Rare Diseases Research at National Institutes of Health from 2015 to 2018, and Chief Medical Officer at Vigil Neuroscience, Inc. Education includes a graduate degree from The Trustees of Columbia University in The City of New York and a doctorate from the University of Bonn.
Cargos activos de Petra Kaufmann
| Empresas | Cargo | Inicio |
|---|---|---|
| OVID THERAPEUTICS INC. | Director Técnico/Científico/I+D | 02/12/2025 |
Antiguos cargos conocidos de Petra Kaufmann.
| Empresas | Cargo | Fin |
|---|---|---|
Affinia Therapeutics, Inc.
 Affinia Therapeutics, Inc. BiotechnologyHealth Technology Develops adeno-associated virus gene therapies | Director Técnico/Científico/I+D | 01/03/2024 |
| AVEXIS INC | Corporate Officer/Principal | 01/02/2021 |
National Institutes of Health
 National Institutes of Health General GovernmentGovernment Engages in the improvement of health and saving lives | Corporate Officer/Principal | 01/02/2018 |
| VIGIL NEUROSCIENCE, INC. | Director Técnico/Científico/I+D | - |
Formación de Petra Kaufmann.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
51
Relaciones de 1er grado
7
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 7 |
|---|---|
Ovid Therapeutics, Inc.
 Ovid Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Provides medicines to children and adults with neurological disorders | Health Technology |
The Trustees of Columbia University in The City of New York
 The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National Institutes of Health
National Institutes of Health General GovernmentGovernment Engages in the improvement of health and saving lives | Government |
University of Bonn
 University of Bonn Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Gene Therapies, Inc.
 Novartis Gene Therapies, Inc. BiotechnologyHealth Technology Operates as a clinical-stage gene therapy company | Health Technology |
Affinia Therapeutics, Inc.
Affinia Therapeutics, Inc. BiotechnologyHealth Technology Develops adeno-associated virus gene therapies | Health Technology |
Vigil Neuroscience, Inc.
 Vigil Neuroscience, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops therapeutics for neurodegenerative diseases | Health Technology |
- Bolsa de valores
- Insiders
- Petra Kaufmann
